3D Systems has appointed Claudia Napal Drayton to its board of directors.
Drayton currently serves as the chief financial officer of Quantum-Si, a life sciences company focused on protein sequencing and genomics technology for the healthcare industry.
Drayton began her career in public accounting with Arthur Andersen and then moved to Medtronic, a global leader in medical devices, where she was chief financial officer for the peripheral vascular and the integrated health solutions business units.
‘We are delighted to welcome Claudia to our board of directors,’ said Chip McClure, chairman. ‘Her outstanding career as a finance leader, in roles ranging from public accounting to sophisticated medical devices and, in recent years, biotech companies, will prove invaluable to both our audit committee and our board in general.’
‘I’m excited about 3D Systems’ history of innovation, and the success it has clearly demonstrated through its focus on the healthcare industry,’ said Drayton. ‘The potential for 3D printing in medical device applications, as well as a tremendous range of biological applications within the human body, offer outstanding opportunities for growth and value creation as new solutions are brought to patients in need around the world.’
This story uses material from 3D Systems; with editorial changes made by Materials Today.
